Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 5 | European Journal of Medical Research

Fig. 5

From: RNA-binding protein DAZAP1 accelerates the advancement of pancreatic cancer by inhibiting ferroptosis

Fig. 5

Downregulation of DAZAP1 inhibited the proliferation of PC cells through ferroptosis. Following the transfection of PANC-1 cells with si-NC and si-DAZAP1 plasmids, ferroptosis inhibitors (Ferrostatin-1 or Liproxstatin-1), necroptosis inhibitor (Necrostatin-1), and pan caspase apoptosis inhibitor (Z-VAD–FMK) were individually added for intervention. A Cell viability was assessed using the CCK-8 assay; B statistical graph of cell proliferation levels across the groups; C cell proliferation was detected using the EdU staining assay. *, **, *** P < 0.05, 0.01, 0.001

Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us